Literature DB >> 7258523

Hemodynamic and metabolic effects of abdominal aortic crossclamping.

J L Falk, E C Rackow, R Blumenberg, M Gelfand, I A Fein.   

Abstract

The hemodynamic and metabolic effects of aortic crossclamping and declamping were studied in 10 patients undergoing abdominal aortic reconstructive surgery. After placement of pulmonary and radial arterial catheters, measurements were obtained preoperatively, during the procedure according to protocol, and postoperatively. Pulmonary arterial wedge pressure was maintained at 10 to 15 mm Hg throughout the operation. Aortic cross clamping produced a significant increase in systemic arteriolar resistance and systolic blood pressure, with no change noted in the left ventricular stroke work index. Declamping decreased systemic resistance and produced no change in the left ventricular stroke work index. Clamping and declamping resulted in elevations of serum lactate. Central venous pressure correlated with pulmonary arterial wedge pressure in each patient and in the entire group. Cardiac function is not decreased by aortic crossclamping, and central venous pressure can usually be used for hemodynamic monitoring in these patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7258523     DOI: 10.1016/0002-9610(81)90270-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Infrarenal aortic clamp reviving a patient from acute surgical haemorrhagic shock: a novel management technique.

Authors:  Ranjith Kumar; M V S Satya Prakash; Subhasree Das; Ramanitharan Manikandan
Journal:  BMJ Case Rep       Date:  2016-10-19

Review 2.  Anaesthesia for abdominal aortic surgery--a review (Part II).

Authors:  A J Cunningham
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

3.  [Intraoperative nitroglycerin: value of determining individual doses: (surgery of the abdominal aorta)].

Authors:  P Combes; J F Payen; M Durand; J L Magne; Y Pra
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.